What Inibsa does

Inibsa (Laboratorios Inibsa S.A.) is a privately held Spanish pharmaceutical company founded in 1948 by Dr. Pedro Junyent in Barcelona, specializing in the development, manufacture, and global distribution of dental anaesthetic products and pain control solutions for dental professionals. The company's core portfolio comprises injectable anaesthetics (Articaine, Lidocaine, Mepivacaine, and Bupivacaine formulations marketed under the Artinibsa, Xilonibsa, Scandinibsa, and Inibsacain brands), topical anaesthetics (Xilonibsa spray 10%), sterile single-use dental needles (MONOPROTECT and MONOPROTECT PLUS lines), and reusable dental cartridge syringes (Prestoject CW, HK, FL, IL, and Safety Stand models). Inibsa is positioned as the world's second-largest producer of dental anaesthesia and serves dental professionals in more than 60 countries through a combination of wholly-owned subsidiaries and distributor networks.

The company operates an 18,000 m² manufacturing and innovation facility in Lliçà de Vall (Barcelona), equipped with optical inspection systems for cartridge quality control, two aseptic filling areas housed in grade B cleanroom environments, and proprietary microbiology (opened 2016), physicochemical (opened 2017), and materials laboratories. Inibsa produces over 1 million dental anaesthetic cartridges per day and holds 100+ pharmaceutical dossiers registered globally. The facility is inspected and approved by major regulatory agencies including AEMPS (Spain), CFDA (China), PPB (Kenya), and the Russian Ministry of Health. Between 2020 and 2022, the entire production plant underwent full renovation and expansion, including two new aseptic fill areas, a transition to RABS (Restricted Access Barrier System), and renewed packaging lines.

Inibsa generates revenue through B2B sales of pharmaceutical and medical-device products to dental professionals via a dual-channel distribution model: wholly-owned subsidiaries in Portugal (since 1960) and Russia (since 2020), plus a network of leading distributors across 50+ additional countries covering Europe, the Middle East, Africa, Asia-Pacific, and the Americas. The company employs more than 375 people, remains privately held with no disclosed parent company or institutional investors, and pursues marketing through clinical educational content (blog), social media (Facebook, Instagram, LinkedIn), and industry conference participation (e.g., AEEDC). Pricing is not publicly disclosed and is handled through distributor and subsidiary relationships.

Name

Inibsa

Legal name

Laboratorios Inibsa S.A.

Website

https://inibsa.com

Company type

Private

Founded year

1948

Operating status

Operating

Headcount range

251–500 employees

Short description

Inibsa is a Spain-based pharmaceutical manufacturer specializing in dental anaesthetics (injectable and topical), dental needles, and syringes. The company serves dental professionals across 60+ countries via direct subsidiaries and distributor networks, and is the world's second-largest producer of dental anaesthesia.

Ownership category

akta.pro rank

Headquarters

HQ city

Llissá De Vall

HQ country

Spain

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical/Medical Device Sales: Revenue generated from manufacturing and selling dental anaesthetics (injectable and topical), dental needles, and dental syringes to dental professionals worldwide through subsidiaries and distributor networks.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Laboratorios Inibsa S.A. manufactures and sells a full dental pain-control portfolio: injectable local anaesthetics (Articaine, Lidocaine, Mepivacaine and Bupivacaine formulations), topical anaesthetics (Lidocaine 10% spray), sterile single-use dental needles, and reusable stainless-steel dental cartridge syringes. The products are sold under Inibsa-owned brands (Artinibsa, Xilonibsa, Scandinibsa, Inibsacain, MONOPROTECT, Prestoject) to dental professionals globally through direct subsidiaries and distributor networks in more than 60 countries.

Product overview

Inibsa is a Spain-based manufacturer of dental anaesthetic products and pain control solutions. The company operates as a single unified product portfolio organized into four main categories: Injectable Anaesthetics (Artinibsa, Xilonibsa, Scandinibsa, and Inibsacain product lines with various concentrations and vasoconstrictor options), Topical Anaesthetics (Xilonibsa spray 10%), Dental Needles (MONOPROTECT® INIBSA and MONOPROTECT® Inibsa PLUS), and Dental Syringes (Prestoject® series including CW, HK, FL, IL models and Safety stand accessory). These products form a comprehensive pain control ecosystem designed for dental professionals, supporting procedures from routine cleanings to complex surgical interventions.

Differentiator

Problem solved

Functional benefit

Brands

• Artinibsa: Articaine-based injectable dental anaesthetic brand (4% with epinephrine 1:100,000 or 1:200,000)
• Xilonibsa
• Scandinibsa
• Inibsacain
• MONOPROTECT
• Prestoject

Products and services

• Artinibsa Injectable Anaesthetics (Articaine 4% with epinephrine) Articaine-based injectable dental anaesthetic with epinephrine (1:100,000 and 1:200,000 variants) for prolonged and medium-duration dental procedures, providing 45–75 minutes of pulpal anaesthesia and extended soft-tissue anaesthesia. Designed for dental professionals performing restorative and surgical procedures.
• Xilonibsa 2% Injectable Anaesthetic (Lidocaine with epinephrine) Lidocaine-based injectable dental anaesthetic (2% with epinephrine 1:80,000), positioned as the gold standard for versatile dental anaesthesia, offering approximately 60 minutes of pulpal anaesthesia and 180 minutes of soft-tissue anaesthesia. Designed for general dental practitioners performing routine procedures.
• Scandinibsa Injectable Anaesthetics (Mepivacaine 2% and 3%) Mepivacaine-based injectable dental anaesthetics available in 3% plain (without vasoconstrictor, for patients where vasoconstrictors are contraindicated) and 2% with epinephrine 1:100,000 formulations, offering short-to-medium pulpal anaesthesia duration suitable for special situations and surgical procedures.
• Inibsacain 0.5% Injectable Anaesthetic (Bupivacaine) Bupivacaine-based long-acting injectable dental anaesthetic (0.5% with epinephrine 1:200,000) for postoperative pain control, providing up to 12 hours of effect and 90–180 minutes of pulpal anaesthesia. Designed for dental practitioners managing post-surgical and complex procedure pain.
• Xilonibsa Spray 10% Topical Anaesthetic Lidocaine 10% topical anaesthetic spray for intraoral surface anaesthesia prior to injection, providing 1–3 minutes of onset and approximately 15 minutes of duration with a banana flavour. Designed for dental professionals to minimise injection discomfort.
• MONOPROTECT INIBSA Sterile Single-Use Dental Needles Sterile single-use dental needles with stainless-steel cannulas, silicon-coated tip and triple-bevel design for smooth and precise injections. Available in multiple gauges (27G–30G) and lengths (12mm–36mm). Designed for dental professionals performing routine injectable anaesthesia.
• MONOPROTECT Inibsa PLUS Dental Needles Enhanced sterile single-use dental needles with a 43% wider inner diameter for smoother flow of anaesthetic solution, lower injection pressure and easier aspiration technique. Designed for dental practitioners seeking premium flow performance in injectable anaesthesia.
• Prestoject Dental Syringes (CW, HK, FL, IL models) Stainless-steel reusable dental cartridge syringes for 1.8 mL dental cartridges, with ergonomic designs for secure, comfortable grip and high resistance to cleaning agents, suitable for thermal disinfection and 134°C sterilisation. Models include CW (Crawford-tip aspirating), HK (three-hook aspirating), FL (self-aspirating flat-tip) and IL (intraligamental with anti-bursting sleeve). Designed for dental professionals performing injectable anaesthesia across different clinical techniques.
• Prestoject Safety Stand Needle recapping device and syringe holder made of heavy stainless steel with mechanical locking, designed to prevent needle-stick injuries during dental treatment. Aimed at dental practitioners seeking enhanced safety accessories for their injection workflow.

Quantifiable outcome

• Products available in more than 60 countries
• +2 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Seven partnerships are on record, tiered minor.

• Hospital Sant Joan de Déu BarcelonaminorOthers · 1 January 2024Social responsibility partnership involving participation in Magic Line 2024 with a donation of 5000 euros to support hospital activities.
• Fundació Somni dels NensminorOthers · 1 January 2024Collaboration to help children with cancer or chronic illnesses through charitable activities.
• IDIBELL (Fundació Institut d'Investigació Biomèdica de Bellvitge)minorOthers · 1 January 2024Sponsorship supporting patients with hereditary conditions resulting in gastrointestinal tumors.
• Fundació Banc dels AlimentsminorOthers · 1 January 2024Financial collaboration by Inibsa employees to support individuals at risk of food insecurity.
• ROV DENTAL (Madagascar)minorChannel Partner/ Reseller/ Distributor · 1 January 2024Local distributor in Madagascar for donation of products for charitable dental activities.
• Fundo iMM-Laço (Portugal)minorOthers · 1 January 2024Donation to fight breast cancer through their local Portugal subsidiary.
• AMPBD - Association Marocaine de Prévention Bucco-DentaireminorOthers · 1 January 2024Collaboration through local distributor Hemolab to promote oral hygiene and access to oral health in Morocco.

Scale indicators7 records

Recent moves4 records

Direct peers

• Septodont: Global #1 in dental anesthetics headquartered in France. Septodont is the most direct competitor to Inibsa — both manufacture injectable dental anesthetics (articaine, lidocaine, mepivacaine) and sell globally to dental professionals, competing head-to-head on the same product category and customer base.
• Pierrel: Italy-based pharmaceutical manufacturer specializing in dental anesthetics and related products. Pierrel competes directly with Inibsa in dental injectable anesthetics and serves overlapping European and international dental professional markets.
• New Stetic: Colombian manufacturer of dental anesthetics and consumables with strong Latin American presence. New Stetic is a direct competitor in the dental injectable anesthetic category and overlaps with Inibsa in cartridge-based local anesthetics.

Broad incumbents

• Dentsply Sirona: Largest dental equipment and consumables manufacturer globally, publicly listed. Dentsply Sirona offers endodontic, restorative, and a broader dental consumables portfolio that overlaps with Inibsa's needles and syringes categories, though it is not focused on injectable anesthetics.
• Henry Schein: Largest dental distributor globally and a major force in dental practice supplies. Henry Schein serves the same dental professional customer base as Inibsa and competes indirectly as a platform that aggregates competing anesthetic brands for sale to practitioners.
• 3M Oral Care Solutions: Large global healthcare conglomerate with a meaningful dental and oral care business. 3M competes adjacent to Inibsa in dental restoratives, preventive products, and certain dental supplies sold to the same professional customer base.

Emerging players

• Ultradent Products: US-based manufacturer of dental materials including anesthetics, hemostatic agents, and restorative products. Ultradent overlaps with Inibsa in topical and injectable dental anesthetics, with partial overlap in needles/syringes via consumable accessories.
• Coltène/Whaledent: Swiss dental manufacturer focused on endodontics, restorative materials, and rotary instruments. Coltene is comparable as a mid-sized specialty dental manufacturer selling consumables to dental professionals, with overlap in needle/syringe-adjacent categories.
• DMG Dental (Dental Manufacturing Group): German dental materials manufacturer specializing in restoratives, preventive care, and digital dentistry workflows. DMG is comparable as a privately held, mid-sized European dental specialty manufacturer serving the same dental professional customer base.

Regional players

• ICPA Health Products (Indian Health Products & Cosmetics Association member manufacturers): Indian dental pharmaceutical manufacturer specializing in local anesthetics and dental products. ICPA is comparable as a regional dental anesthetic manufacturer serving South Asian and emerging markets, overlapping with Inibsa in injectable dental anesthetics but in different geographies.

Market position

Strengths4 records

Weaknesses4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/InibsaInternational
• LinkedInlinkedin.com/company/inibsagrupo
• Instagraminstagram.com/inibsa
• Xx.com/inibsadental

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Inibsa